1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
Circulating Nucleic Acids (CNAs) Based Non-Invasive Cancer Diagnostics: A Global Market Report

Circulating Nucleic Acids (CNAs) Based Non-Invasive Cancer Diagnostics: A Global Market Report

  • July 2014
  • 219 pages
  • ID: 2264764
  • Format: PDF
  • By Veracity Health


Table of Contents

Search Inside

ES.1 Introduction to the Circulating Nucleic Acid Market Report
The aim of this report was to review recent advances in use of circulating cell-free miRNA, DNA and mRNA as novel biomarkers which can be used for the detection and diagnosis of cancer, and the impact on making the ongoing research closer to clinical application. The report will also provide a market analysis of the market value, growth rates, market development as well as examining the dynamics and factors influencing the growth and development of this market. This report also looks at the challenges and potential threats facing the industry players, and the factors influencing the market shares of both the major market suppliers and smaller indigenous manufacturers in local markets.

The data collection and forecasting methods used in the preparation of this report are broadly divided into three methods. These are primary data and information gathering, secondary data and information gathering and market share analysis and market forecast prediction. Information and data including estimates on market values, growth rates and market share data were gathered from the methods described and were incorporated into proprietary computer forecasting and market share analysis models. The forecast model was used to derive market estimates for future years. It incorporates a rate factor, which helps determine the speed with which the market develops, which is similar to that observed for markets for other medical products and is adjusted to match historic data for the market under analysis.

ES.2 Background to Circulating Nucleic Acids
This chapter reviews the historical developments that have excited researchers and clinicians alike illustrating the practical applications for elevated circulating nucleic acids (CNA) levels for the detection of cancer and identifying the different categories or types of CNAs which are known to be present circulating in serum and plasma. This chapter also identifies the top molecular CNA characterisation techniques and technologies which are used to identify and measure CNAs.

Since the discovery of circulating nucleic acids in plasma in 1948, many diagnostic applications have emerged. For example, diagnostic and prognostic potentials of circulating tumor'derived DNA have been demonstrated for many types of cancer. The parallel development of foetal'derived DNA detection in maternal plasma has opened up the possibility of non'invasive prenatal diagnosis and monitoring of many pregnancy'associated disorders. This is the subject of a distinct report also available from Veracity Health.

ES.3 Cancer: A Statistical Analysis of the Disease Incidence and Prevalence
Cancer is a class of many diseases characterized by uncontrolled division of cells and the ability of these cells to invade other tissues, either by direct growth into adjacent tissues or transportation through the blood or lymphatic system into distant sites by metastasis. Although cancer may occur at any age, risk increases as one ages, and the disease is one of the leading causes of death in industrialized countries.

Severity of symptoms depends on the site and character of the malignancy and whether metastasis is involved. A definitive diagnosis typically requires histologic examination of tissue obtained by biopsy or surgery. Most cancers may be treated and some cured, depending on the type, location, and stage. Once diagnosed, cancer typically is treated with a combination of methods including chemotherapy, radiotherapy, and surgery.

A detailed analysis of the estimated global incidence rates, mortality rates and 5-year prevalence rates for both males and females by cancer types in 2012 has been carried out illustrating the depth and breadth of this global issue.

ES.4 CNA Based Cancer Diagnostics Market: Revenue Analysis
An analysis of the revenues and forecasts for the global cancer CNA biomarker market with a further more detailed analysis and forecast of the revenues for the global market sub-divided by major market sub-segments by geographic region and finally by selected country.
This chapter also reviews the principal market drivers and restraints affecting and influencing the development of this market.

Please note that with the exception of North America each of the geographic regions analyzed include other individual countries in these geographic regions. For the purposes of clarity within this report although these other remaining countries in these geographic regions have been analyzed the market values and market shares have not been included. Should the reader require more detailed information about these countries the author of this report will be able to provide a customized report providing the additional information that would be required.

Exhibit E.S. 1 provides a summary review of the revenue forecasts analysis for global non-invasive cancer diagnostics market utilising technologies associated with the detection of circulating nucleic acids between 2010 and 2020.

Veracity Health has determined that the global market was almost non-existent as products had not been available commercially in 2010. By the year 2013 a number of commercially available products had entered the market. By 2013 the global market had increased in value to an estimated $186.8 million and by using a proprietary forecast spreadsheet which took into account the market variables a prediction that by the end of the forecast period the market is predicted to grow to $6,216 million (CAGR 2013-2020 of 65.0%).

The valuation of the market reflects the changes to the economic, demographic and market variables which are affecting the value of the market. These include the:
- predicted relative decrease in product pricing as the market matures and as new lower priced products enter the market over the forecast period,
- impact of the greater access and acceptability of non-invasive cancer diagnostic testing in preference to the traditional methods of invasive sample testing and imaging technologies.
- impact of the current global recession and its effect on the funding of national healthcare systems and specifically the diagnostics services within each national state.

ES.5 CNA Based Cancer Diagnostics Market: Market Share Analysis
An analysis of the global market share together with a further more detailed analysis of the market share by geographic regions and finally by selected country has been provided. This illustrates the structure and organisation of the current market, highlighting the leading players and other companies operating in it.

Exhibit E.S. 2 provides a summary of the market shares for the global non-invasive cancer diagnostics market based on circulating nucleic acids and technologies associated with the detection of CNAs market in 2013. The global market is highly fragmented as a result of the wide variety of different new and innovative technologies which have been developed and currently available and new technologies which are presently in the research phase and/or being developed.

The leading companies as identified in this analysis are Qiagen N.V., Invitrogen, Roche, Thermo Fischer Scientific, Inc (Life Technologies), Illumina, Affymetrix, Becton, Dickinson and Company, Siemens and Hologic Gen-Probe. It has been estimated that the top 6 majorplayers as shown in Exhibit E.S. 2 and illustrated in Exhibit E.S. 3 account for an estimated 60.4% of the global market in 2013 with the market leader Qiagen N.V., accounting for 18.8% of the market or the equivalent of $35.1 million in revenues.
Veracity Health has determined that Invitrogen is the second largest supplier of current non-invasive cancer diagnostic products with an estimated 10.1% of the global market or the equivalent of sales valued at $19.0 million. Invitrogen is one of several brands under the Life Technologies brand of the Thermo Fischer Scientific corporation. The market share of Invitrogen in combination with Life Technologies is estimated to be approximately 19.1% and in some specific countries is higher.

ES.6 Company Profiles
This chapter provides the profiles of the leading 25 companies involved in the development, manufacture and marketing of devices which incorporate the technologies used for the detection of CNAs. It provides a review of their historical development, main product areas, including products in developments, as well as short reviews of their key proprietary technologies.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Global RNA Analysis/Transcriptomics Industry

Global RNA Analysis/Transcriptomics Industry

  • $ 4950
  • October 2019

RNA Analysis/Transcriptomics market worldwide is projected to grow by US$4.8 Billion, driven by a compounded growth of 13.9%. Microarray, one of the segments analyzed and sized in this study, displays ...

Healthcare-associated Infectious Disease Diagnostics Market - Global Outlook and Forecast 2019-2024

Healthcare-associated Infectious Disease Diagnostics Market - Global Outlook and Forecast 2019-2024

  • $ 3500
  • October 2019

The healthcare-associated infectious disease diagnostics market is expected to grow at a CAGR of over 8% during the period 2018–2024.The growing demand for POC tests for the diagnosis of HAIs will have ...

Global Liquid Biopsy Market - Opportunities and Forecast (2017-2024)

Global Liquid Biopsy Market - Opportunities and Forecast (2017-2024)

  • $ 1800
  • October 2019

Executive SummaryAccording to the report, the Liquid Biopsy was valued at USD 899.55 million for the year 2018.Over the recent years, Liquid Biopsy has been witnessing considerable growth on the back of ...


Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on